Combating infectious diseases and the threat of antimicrobial resistance remains one of the greatest global challenges.
Cambridge start-up SMi and its research partners have received two Innovate UK awards to progress their work on testing for infectious diseases and...
Plan will accelerate a new approach to coronavirus vaccines research and development, to protect against COVID-19 variants and future pandemic...
Scientists may have solved the question of why Ashkenazi Jews are significantly more susceptible to a rare genetic disorder known as Gaucher disease...
COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future ‘...
Cambridge scientists have identified a drug that can be repurposed to prevent COVID-19 in research involving a unique mix of ‘mini-organs’, donor...
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being...
Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the...
Cambridge is among 12 institutions across the UK that will be working together to tackle the monkeypox outbreak, developing better diagnostic tests...
Referrals to Cambridge’s long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the...
First ancient herpes genomes to be sequenced suggest a Bronze Age flourishing linked to migrations into Europe and possibly the emergence of kissing.
Scientists say continuous monitoring of the cholera bug genome is key to preventing outbreaks of new variants.
A new study has found that a highly antibiotic-resistant strain of the superbug MRSA – methicillin resistant Staphylococcus aureus – has emerged in...
